Published in Anal Bioanal Chem on March 12, 2010
High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev (2013) 1.23
Glycoproteomic analysis of antibodies. Mol Cell Proteomics (2013) 1.19
Developments in the identification of glycan biomarkers for the detection of cancer. Mol Cell Proteomics (2013) 1.12
Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease. Mol Cell Proteomics (2013) 1.11
Oligosaccharide analysis by mass spectrometry: a review of recent developments. Anal Chem (2013) 1.10
Stable-isotope labeled hydrophobic hydrazide reagents for the relative quantification of N-linked glycans by electrospray ionization mass spectrometry. Anal Chem (2011) 1.07
Glycomics using mass spectrometry. Glycoconj J (2012) 1.06
Absolute quantitation of immunoglobulin G and its glycoforms using multiple reaction monitoring. Anal Chem (2013) 1.06
Hydrophobic derivatization of N-linked glycans for increased ion abundance in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2011) 0.97
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc Natl Acad Sci U S A (2014) 0.94
N-Glycan profiling of dried blood spots. Anal Chem (2011) 0.93
Advances in analysis of human milk oligosaccharides. Adv Nutr (2012) 0.91
Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery. Acta Biomater (2013) 0.90
Harnessing glycomics technologies: integrating structure with function for glycan characterization. Electrophoresis (2012) 0.89
EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans. Glycobiology (2015) 0.88
Structural Identification of O-Linked Oligosaccharides Using Exoglycosidases and MSn Together with UniCarb-DB Fragment Spectra Comparison. Metabolites (2012) 0.86
Glycan analysis by isobaric aldehyde reactive tags and mass spectrometry. Anal Chem (2013) 0.86
Quantitative glycomics strategies. Mol Cell Proteomics (2013) 0.85
Systematic comparison of reverse phase and hydrophilic interaction liquid chromatography platforms for the analysis of N-linked glycans. Anal Chem (2012) 0.85
The GlycoFilter: a simple and comprehensive sample preparation platform for proteomics, N-glycomics and glycosylation site assignment. Mol Cell Proteomics (2013) 0.84
Parasites, proteomes and systems: has Descartes' clock run out of time? Parasitology (2012) 0.84
Glycoprotein disease markers and single protein-omics. Mol Cell Proteomics (2013) 0.83
LC-MS3 quantification of O-glycopeptides in human serum. Electrophoresis (2013) 0.82
Dual modifications strategy to quantify neutral and sialylated N-glycans simultaneously by MALDI-MS. Anal Chem (2014) 0.82
Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS). Mol Cell Proteomics (2013) 0.82
Electron detachment dissociation of fluorescently labeled sialylated oligosaccharides. Electrophoresis (2011) 0.82
Oxidative release of natural glycans for functional glycomics. Nat Methods (2016) 0.81
Solid-phase glycan isolation for glycomics analysis. Proteomics Clin Appl (2012) 0.81
Glycan analysis of therapeutic glycoproteins. MAbs (2015) 0.81
Reversed-phase liquid-chromatographic mass spectrometric N-glycan analysis of biopharmaceuticals. Anal Bioanal Chem (2013) 0.81
Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples. J Proteome Res (2015) 0.80
Small scale affinity purification and high sensitivity reversed phase nanoLC-MS N-glycan characterization of mAbs and fusion proteins. MAbs (2014) 0.80
Recent advances in cellular glycomic analyses. Biomolecules (2013) 0.80
Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass Spectrometry. Chromatographia (2014) 0.80
A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins. J Proteome Res (2015) 0.79
Structural Characterization of Carbohydrates by Fourier Transform Tandem Mass Spectrometry. Curr Proteomics (2011) 0.79
Chemoenzymatic method for glycomics: Isolation, identification, and quantitation. Proteomics (2015) 0.78
Glycoproteomic and glycomic databases. Clin Proteomics (2014) 0.78
Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities. Electrophoresis (2016) 0.77
Quantitation of permethylated N-glycans through multiple-reaction monitoring (MRM) LC-MS/MS. J Am Soc Mass Spectrom (2015) 0.77
Comparative Analysis of End Point Enzymatic Digests of Arabino-Xylan Isolated from Switchgrass (Panicum virgatum L) of Varying Maturities using LC-MSn. Metabolites (2012) 0.77
QUANTITY: An Isobaric Tag for Quantitative Glycomics. Sci Rep (2015) 0.77
Purification of derivatized oligosaccharides by solid phase extraction for glycomic analysis. PLoS One (2014) 0.76
High-temperature LC-MS/MS of permethylated glycans derived from glycoproteins. Electrophoresis (2016) 0.76
Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry. Anal Bioanal Chem (2012) 0.76
Development of a multifunctional aminoxy-based fluorescent linker for glycan immobilization and analysis. Glycobiology (2016) 0.75
Reversed-phase separation methods for glycan analysis. Anal Bioanal Chem (2016) 0.75
Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans. Mol Cell Proteomics (2016) 0.75
A cationic cysteine-hydrazide as an enrichment tool for the mass spectrometric characterization of bacterial free oligosaccharides. Anal Bioanal Chem (2015) 0.75
Mass Spectrometry-Based N-Glycomics of Colorectal Cancer. Int J Mol Sci (2015) 0.75
Application of carbohydrate arrays coupled with mass spectrometry to detect activity of plant-polysaccharide degradative enzymes from the fungus Aspergillus niger. Sci Rep (2017) 0.75
Characterization of isomeric glycan structures by LC-MS/MS. Electrophoresis (2017) 0.75
Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem (2007) 6.80
Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature (1985) 5.32
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71
Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem (1995) 2.65
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology (2007) 2.45
Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res (2009) 2.39
Mass spectrometry of oligosaccharides. Mass Spectrom Rev (2004) 2.38
Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom (2005) 2.27
Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics (2008) 2.26
A general approach to desalting oligosaccharides released from glycoproteins. Glycoconj J (1998) 2.10
Glycosylation of recombinant antibody therapeutics. Biotechnol Prog (2005) 2.09
Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry. Anal Biochem (2002) 1.93
HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem (2007) 1.92
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology (2003) 1.91
Structural investigations of glycoconjugates at high sensitivity. Chem Rev (2002) 1.79
High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.74
Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med (1988) 1.72
IgG glycosylation analysis. Proteomics (2009) 1.71
Analysis of protein glycosylation by mass spectrometry. Nat Protoc (2007) 1.65
GlycoBase and autoGU: tools for HPLC-based glycan analysis. Bioinformatics (2008) 1.64
Hydrophilic interaction chromatography. J Sep Sci (2006) 1.56
Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim Biophys Acta (2005) 1.56
Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal Chem (2007) 1.54
Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE). Glycobiology (2000) 1.52
Glycoform quantification of chondroitin/dermatan sulfate using a liquid chromatography-tandem mass spectrometry platform. Biochemistry (2006) 1.51
Quantitative determination of monosaccharides in glycoproteins by high-performance liquid chromatography with highly sensitive fluorescence detection. Anal Biochem (1994) 1.50
Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment. Glycobiology (2001) 1.45
Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol (2006) 1.43
Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interactions. Chem Biol (2007) 1.42
Fragmentation of negative ions from carbohydrates: part 3. Fragmentation of hybrid and complex N-linked glycans. J Am Soc Mass Spectrom (2005) 1.42
Versatile fluorescent derivatization of glycans for glycomic analysis. Nat Methods (2005) 1.41
Fragmentation of negative ions from carbohydrates: part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates. J Am Soc Mass Spectrom (2005) 1.40
A glycomics platform for the analysis of permethylated oligosaccharide alditols. J Am Soc Mass Spectrom (2007) 1.38
Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem (2001) 1.38
Fragmentation of negative ions from carbohydrates: part 2. Fragmentation of high-mannose N-linked glycans. J Am Soc Mass Spectrom (2005) 1.35
Quantitation by isobaric labeling: applications to glycomics. J Proteome Res (2007) 1.34
Collision-induced fragmentation of underivatized N-linked carbohydrates ionized by electrospray. J Mass Spectrom (2000) 1.32
Glycome mapping on DNA sequencing equipment. Nat Protoc (2006) 1.32
Glycan reductive isotope labeling for quantitative glycomics. Anal Biochem (2009) 1.31
Tools for glycomics: relative quantitation of glycans by isotopic permethylation using 13CH3I. Glycobiology (2007) 1.30
Progress in boronic acid-based fluorescent glucose sensors. J Fluoresc (2004) 1.29
Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates. Anal Biochem (2005) 1.27
Tags for the stable isotopic labeling of carbohydrates and quantitative analysis by mass spectrometry. Anal Chem (2007) 1.27
Comparative glycomic mapping through quantitative permethylation and stable-isotope labeling. Anal Chem (2007) 1.26
Electrophoretic analysis of N-glycans on microfluidic devices. Anal Chem (2007) 1.26
An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. Anal Biochem (2002) 1.25
Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry. Mass Spectrom Rev (2009) 1.24
Strategies for analysis of glycoprotein glycosylation. Biochim Biophys Acta (2006) 1.23
Comparative glycomics of connective tissue glycosaminoglycans. Proteomics (2008) 1.22
Protein glycosylation analysis by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.20
The high mannose glycans from bovine ribonuclease B isomer characterization by ion trap MS. J Am Soc Mass Spectrom (2008) 1.20
Influence of electrosorption, solvent, temperature, and ion polarity on the performance of LC-ESI-MS using graphitic carbon for acidic oligosaccharides. Anal Chem (2008) 1.19
Oligosaccharide analysis by graphitized carbon liquid chromatography-mass spectrometry. Anal Bioanal Chem (2009) 1.18
A chip-based amide-HILIC LC/MS platform for glycosaminoglycan glycomics profiling. Proteomics (2009) 1.17
High resolution and high sensitivity methods for oligosaccharide mapping and characterization by normal phase high performance liquid chromatography following derivatization with highly fluorescent anthranilic acid. Glycobiology (1998) 1.16
IDAWG: Metabolic incorporation of stable isotope labels for quantitative glycomics of cultured cells. J Proteome Res (2009) 1.15
Structural analysis of underivatized neutral human milk oligosaccharides in the negative ion mode by nano-electrospray MS(n) (part 2: application to isomeric mixtures). J Am Soc Mass Spectrom (2002) 1.14
Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J (1997) 1.14
On-line CE-LIF-MS technology for the direct characterization of N-linked glycans from therapeutic antibodies. Anal Chem (2008) 1.14
Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins. Anal Chem (2008) 1.13
General microarray technique for immobilization and screening of natural glycans. Anal Chem (2007) 1.13
Structure elucidation of arabinoxylan isomers by normal phase HPLC-MALDI-TOF/TOF-MS/MS. Carbohydr Res (2006) 1.13
Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography/mass spectrometry. Anal Biochem (2007) 1.12
Normal-phase nanoscale liquid chromatography-mass spectrometry of underivatized oligosaccharides at low-femtomole sensitivity. Anal Chem (2004) 1.12
Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures. Glycobiology (2000) 1.11
Preparation and desorption mass spectrometry of permethyl and peracetyl derivatives of oligosaccharides. Methods Enzymol (1990) 1.11
Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans. Mol Cell Proteomics (2007) 1.11
Derivatization of sialic acids for stabilization in matrix-assisted laser desorption/ionization mass spectrometry and concomitant differentiation of alpha(2 --> 3)- and alpha(2 --> 6)-isomers. Rapid Commun Mass Spectrom (2009) 1.08
Surface plasmon resonance imaging for real-time, label-free analysis of protein interactions with carbohydrate microarrays. Glycoconj J (2007) 1.06
Structural analysis of underivatized neutral human milk oligosaccharides in the negative ion mode by nano-electrospray MS(n) (part 1: methodology). J Am Soc Mass Spectrom (2002) 1.05
Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J (2008) 1.05
Carbohydrate analysis of a chimeric recombinant monoclonal antibody by capillary electrophoresis with laser-induced fluorescence detection. Anal Chem (1999) 1.05
High-sensitivity and high-resolution methods for glycoprotein analysis. Anal Biochem (2000) 1.05
Oligosaccharide relative quantitation using isotope tagging and normal-phase liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.04
Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophils. Exp Hematol (2009) 1.03
Isotope tag method for quantitative analysis of carbohydrates by liquid chromatography-mass spectrometry. J Chromatogr A (2005) 1.02
Saccharide linkage analysis using methylation and other techniques. Methods Enzymol (1994) 1.02
Capillary gel electrophoresis separation of high-mannose type oligosaccharides derivatized by 1-aminopyrene-3,6,8-trisulfonic acid. Electrophoresis (1995) 1.02
Structural determination of neutral O-linked oligosaccharide alditols by negative ion LC-electrospray-MSn. J Am Soc Mass Spectrom (2004) 1.02
Recovery of intact 2-aminobenzamide-labeled O-glycans released from glycoproteins by hydrazinolysis. Anal Biochem (2002) 1.01
Serum antibody screening by surface plasmon resonance using a natural glycan microarray. Glycoconj J (2008) 1.00
Glycoprotein characterization combining intact protein and glycan analysis by capillary electrophoresis-electrospray ionization-mass spectrometry. Anal Chem (2006) 0.99
A rapid sample preparation method for mass spectrometric characterization of N-linked glycans. Rapid Commun Mass Spectrom (2005) 0.98
Structural analysis of sulfated glycans by sequential double-permethylation using methyl iodide and deuteromethyl iodide. J Am Soc Mass Spectrom (2009) 0.97
Nonreductive release of O-linked oligosaccharides from mucin glycoproteins for structure/function assignments as neoglycolipids: application in the detection of novel ligands for E-selectin. Glycobiology (1997) 0.97
Matrix-assisted laser desorption/ionization mass spectrometry compatible beta-elimination of O-linked oligosaccharides. Rapid Commun Mass Spectrom (2002) 0.97
Comparison of fluorescent labels for oligosaccharides and introduction of a new postlabeling purification method. Anal Biochem (2008) 0.96
Glycomic analysis by capillary electrophoresis-mass spectrometry. Mass Spectrom Rev (2009) 0.96
Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis. J Chromatogr A (2004) 0.95
Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography. Anal Biochem (1995) 0.95
Glycoproteomics of milk: differences in sugar epitopes on human and bovine milk fat globule membranes. J Proteome Res (2008) 0.95
Three-dimensional mapping of N-linked oligosaccharides using anion-exchange, hydrophobic and hydrophilic interaction modes of high-performance liquid chromatography. J Chromatogr A (1996) 0.94
Development of a single column method for the separation of lipid- and protein-derived oligosaccharides. J Proteome Res (2009) 0.94
Repeats of LacdiNAc and fucosylated LacdiNAc on N-glycans of the human parasite Schistosoma mansoni. FEBS J (2006) 0.94
Biotinyl-l-3-(2-naphthyl)-alanine hydrazide derivatives of N-glycans: versatile solid-phase probes for carbohydrate-recognition studies. Glycobiology (1998) 0.93
Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies. J Chromatogr A (2006) 0.93
Hydrophilic-interaction chromatography of complex carbohydrates. J Chromatogr A (1994) 0.92
Capillary zone electrophoresis of linear and branched oligosaccharides. J Chromatogr (1992) 0.92
Oligosaccharide analysis by capillary-scale high-pH anion-exchange chromatography with on-line ion-trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.90
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet (2000) 4.32
Diagnosis of schistosomiasis by reagent strip test for detection of circulating cathodic antigen. J Clin Microbiol (2004) 1.96
Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis (1996) 1.87
Application of a circulating-cathodic-antigen (CCA) strip test and real-time PCR, in comparison with microscopy, for the detection of Schistosoma haematobium in urine samples from Ghana. Ann Trop Med Parasitol (2008) 1.78
Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop (2000) 1.69
Schistosoma mansoni: demonstration of two circulating antigens in infected hamsters. Exp Parasitol (1976) 1.35
Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis. Eur J Clin Microbiol Infect Dis (1997) 1.35
Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg (1995) 1.32
The immunologically reactive O-linked polysaccharide chains derived from circulating cathodic antigen isolated from the human blood fluke Schistosoma mansoni have Lewis x as repeating unit. Eur J Biochem (1994) 1.24
Specificity of circulating antigen detection for schistosomiasis mansoni in Senegal and Burundi. Trop Med Int Health (2000) 1.23
Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis (1998) 1.21
Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age. Infect Immun (1999) 1.18
Mass spectrometry proteomic diagnosis: enacting the double cross-validatory paradigm. J Comput Biol (2006) 1.17
Epidemiology of Schistosoma mansoni infection in a recently exposed community in northern Senegal. Am J Trop Med Hyg (1993) 1.16
Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol (1996) 1.12
Rapid diagnosis of schistosomiasis by antigen detection in urine with a reagent strip. J Clin Microbiol (1994) 1.12
Detection of the schistosome circulating cathodic antigen by enzyme immunoassay using biotinylated monoclonal antibodies. Trans R Soc Trop Med Hyg (1991) 1.11
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Epidemiologic application of circulating antigen detection in a recent Schistosoma mansoni focus in northern Senegal. Am J Trop Med Hyg (1995) 1.09
Detection of schistosome antigen in mummies. Lancet (1990) 1.08
A simple and rapid treatment (trichloroacetic acid precipitation) of serum samples to prevent non-specific reactions in the immunoassay of a proteoglycan. J Immunol Methods (1987) 1.08
Immunodiagnosis of recently acquired Schistosoma mansoni infection. A comparison of various immunological techniques. Trop Geogr Med (1981) 1.06
Immunodiagnosis of schistosomiasis mansoni in a low endemic area in Surinam by determination of the circulating antigens CAA and CCA. Acta Trop (1995) 1.06
A comparative study on specific antibodies and circulating antigen (CAA) in serum and parasitological findings for diagnosis of schistosomiasis mansoni in an endemic area in Tanzania. Acta Trop (1996) 1.03
An immunofluorescence reaction for Schistosoma manosoni using the defined antigen substrate spheres (DASS) system. J Immunol Methods (1974) 1.03
Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings. Am J Trop Med Hyg (1999) 1.02
Schistosoma mansoni: characterization of two circulating polysaccharide antigens and the immunological response to these antigens in mouse, hamster, and human infections. Exp Parasitol (1980) 1.01
Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis. Trans R Soc Trop Med Hyg (2008) 1.00
Mapping fucosylated epitopes on glycoproteins and glycolipids of Schistosoma mansoni cercariae, adult worms and eggs. Parasitology (2005) 1.00
Serum antibody screening by surface plasmon resonance using a natural glycan microarray. Glycoconj J (2008) 1.00
Circulating anodic and cathodic antigen in serum and urine from Schistosoma haematobium-infected Cameroonian children receiving praziquantel: a longitudinal study. Clin Infect Dis (1994) 0.99
Antibody response patterns against Schistosoma mansoni in a recently exposed community in Senegal. J Infect Dis (1996) 0.99
Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal. Am J Trop Med Hyg (1997) 0.98
Magnetic bead antigen capture enzyme-linked immunoassay in microtitre trays for rapid detection of schistosomal circulating anodic antigen. J Immunol Methods (1992) 0.98
Circulating anodic antigen levels in serum before and after chemotherapy with praziquantel in schistosomiasis mansoni. Trans R Soc Trop Med Hyg (1990) 0.98
Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child. Infection (1995) 0.98
Immunoelectron microscopical localization of a circulating antigen in the excretory system of Schistosoma mansoni. Ultrastructural localization studies of the excretory system of S. mansoni. Parasitol Res (1995) 0.98
Immunofluorescent visualization of the excretory and gut system of Schistosoma mansoni by confocal laser scanning microscopy. Am J Trop Med Hyg (1994) 0.97
Profiles of immunoglobulin M (IgM) and IgG antibodies against defined carbohydrate epitopes in sera of Schistosoma-infected individuals determined by surface plasmon resonance. Infect Immun (2001) 0.95
Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report. Acta Trop (1996) 0.95
Schistosomal specific nephropathy leading to end-stage renal failure. Kidney Int (1987) 0.95
Schistosoma mansoni: in vitro and in vivo excretion of CAA and CCA by developing schistosomula and adult worms. J Parasitol (1996) 0.94
Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun (2001) 0.94
Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears. World J Gastroenterol (2006) 0.93
Characterization of N-glycans from mouse brain neural cell adhesion molecule. Glycobiology (2001) 0.93
Detection of circulating anodic antigen by ELISA for seroepidemiology of schistosomiasis mansoni. Trans R Soc Trop Med Hyg (1988) 0.93
Molecular characterisation of kappa-5, a major antigenic glycoprotein from Schistosoma mansoni eggs. Mol Biochem Parasitol (2009) 0.93
Circulating cathodic antigen levels in serum and urine of schistosomiasis patients before and after chemotherapy with praziquantel. Trans R Soc Trop Med Hyg (1993) 0.92
An indirect haemagglutination reaction for the demonstration of Schistosoma mansoni circulating anodic antigen. Trans R Soc Trop Med Hyg (1978) 0.92
Levels of the schistosome circulating anodic and cathodic antigens in serum of schistosomiasis patients from Brazil. Trans R Soc Trop Med Hyg (1992) 0.92
Adhesion molecules in intestinal Schistosoma mansoni infection. Parasitol Res (1998) 0.92
Day-to-day fluctuation of schistosome circulating antigen levels in serum and urine of humans infected with Schistosoma mansoni in Burundi. Am J Trop Med Hyg (1998) 0.92
Palaeoepidemiology of Schistosoma infection in mummies. BMJ (1992) 0.91
Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals. J Infect Dis (1997) 0.91
Schistosoma mansoni: comparison of the immunoperoxidase techniques, DASS and ELISA, for human diagnosis. Exp Parasitol (1977) 0.91
Dominant antibody responses to Fucalpha1-3GalNAc and Fucalpha1-2Fucalpha1-3GlcNAc containing carbohydrate epitopes in Pan troglodytes vaccinated and infected with Schistosoma mansoni. Exp Parasitol (2004) 0.91
The relationship between worm burden and levels of a circulating antigen (CAA) of five species of Schistosoma in mice. Parasitology (1995) 0.90
Ultrastructural localization of the circulating anodic antigen in the digestive tract of Schistosoma mansoni using monoclonal antibodies in an immunogold labeling procedure. Am J Trop Med Hyg (1986) 0.90
Antimicrobial, antiamoebic and antiviral screening of some Tabernaemontana species. Planta Med (1984) 0.89
Schistosome glycoconjugates in host-parasite interplay. Glycoconj J (2001) 0.89
Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children. Clin Infect Dis (1998) 0.89
Presence of the schistosome circulating anodic antigen (CAA) in urine of patients with Schistosoma mansoni or S. haematobium infections. Am J Trop Med Hyg (1989) 0.89
Monitoring the efficacy of different doses of praziquantel by quantification of circulating antigens in serum and urine of schistosomiasis patients. Parasitology (1994) 0.89
Effect of partial portal vein ligation on immune glomerular deposits in Schistosoma mansoni-infected mice. Br J Exp Pathol (1977) 0.89
Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans. Am J Trop Med Hyg (1996) 0.88
Antibody responses to Ascaris-derived proteins and glycolipids: the role of phosphorylcholine. Parasite Immunol (2006) 0.88
Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B. J Immunol (1984) 0.88
H-2 linked immune response to murine experimental Schistosoma mansoni infections. J Immunogenet (1979) 0.88
Applicability of different antigen preparations in the enzyme-linked immunosorbent assay for schistosomiasis mansoni. Am J Trop Med Hyg (1980) 0.88
Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya. Am J Trop Med Hyg (1999) 0.87
Schistosome circulating anodic antigen in serum of individuals infected with Schistosoma japonicum from the Philippines before and after chemotherapy with praziquantel. Trans R Soc Trop Med Hyg (1992) 0.87
Levels of circulating soluble egg antigen in urine of individuals infected with Schistosoma mansoni before and after treatment with praziquantel. Trans R Soc Trop Med Hyg (1999) 0.87
Daily fluctuation of levels of circulating cathodic antigen in urine of children infected with Schistosoma mansoni in Brazil. Trans R Soc Trop Med Hyg (1997) 0.87
Fluctuation of schistosome circulating antigen levels in urine of individuals with Schistosoma mansoni infection in Burundi. Am J Trop Med Hyg (1996) 0.87
Comparison of four schistosome excretory-secretory antigens: phenol sulfuric test active peak, cathodic circulating antigen, gut-associated proteoglycan, and circulating anodic antigen. Am J Trop Med Hyg (1985) 0.87
Structural analysis of glycoconjugates by on-target enzymatic digestion and MALDI-TOF-MS. Anal Chem (1999) 0.87
Total plasma N-glycome changes during pregnancy. J Proteome Res (2014) 0.86
Use of monoclonal antibodies prepared against Schistosoma mansoni hatching fluid antigens for demonstration of Schistosoma haematobium circulating egg antigens in urine. Am J Trop Med Hyg (1998) 0.86
Relating serum circulating anodic antigens to faecal egg counts in Schistosoma mansoni infections: a modelling approach. Parasitology (2000) 0.86
Evaluation of the patterns of Schistosoma mansoni infection and re-infection in Senegal, from faecal egg counts and serum concentrations of circulating anodic antigen. Ann Trop Med Parasitol (2002) 0.86
A simple technique to pretreat urine and serum samples for quantitation of schistosome circulating anodic and cathodic antigen. Acta Trop (1994) 0.86
Schistosoma haematobium-induced glomerular disease: an experimental study in the golden hamster. Nephron (1991) 0.86
High NaCl concentrations induce the nod genes of Rhizobium tropici CIAT899 in the absence of flavonoid inducers. Mol Plant Microbe Interact (2013) 0.86
Effect of anti-schistosomal treatment on schistosomal-specific nephropathy. Nephrol Dial Transplant (1988) 0.85
Response to: accuracy of circulating cathodic antigen tests for rapid mapping of Schistosoma mansoni and S. haematobium infections in Southern Sudan by RA Ashton et al. (2011) Trop Med Int Health 16, pp. 1099-1103. Trop Med Int Health (2011) 0.85
Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy. Am J Trop Med Hyg (1997) 0.85
Detection of the circulating antigens CAA and CCA in a group of Dutch travellers with acute schistosomiasis. Trop Med Int Health (1997) 0.85
Circulating anodic antigen (CAA) levels in different age groups in a Zimbabwean rural community endemic for Schistosoma haematobium determined using the magnetic beads antigen-capture enzyme-linked immunoassay. Am J Trop Med Hyg (1996) 0.85
Antibody response to Schistosoma mansoni adult worm cysteine proteinases in infected individuals. Am J Trop Med Hyg (1990) 0.85
Bovine lymphocytes express functional receptors for Escherichia coli Shiga toxin 1. Microb Pathog (2002) 0.85
[Serodiagnosis of Schistosoma infections]. Ned Tijdschr Geneeskd (1989) 0.84
Schistosoma japonicum: immunological characterization and detection of circulating polysaccharide antigens from adult worms. Exp Parasitol (1983) 0.84
Quantitative determination of circulating anodic and cathodic antigens in serum and urine of individuals infected with Schistosoma intercalatum. Trans R Soc Trop Med Hyg (1993) 0.84
Purification studies on an acidic protease from adult Schistosoma mansoni. Acta Leiden (1977) 0.84